JNJ Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own JNJ shares is 4809, representing 73.25% of the company's common stock.

ROYAL BANK OF CANADA, in the last quarter, reduced its stake in JNJ by -0.91% restricting it's holding to 13.31 million shares of worth nearly $2.11B. NUVEEN ASSET MANAGEMENT, LLC also lessened -1.52% of the JNJ shares from its portfolio, reducing its holding to 9.28 million shares of worth $1.47B. BARCLAYS PLC also shunned JNJ shares holding by -7.13% last quarter which brought its holding to 8.31 million shares worth $1.31B.

As per its latest 13F filing, GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC increased its stake in JNJ by 21.1% in the last quarter. The institutional holder raised its holding to 4.83 million shares having worth more than $763.67M. CANADA PENSION PLAN INVESTMENT BOARD also added 25.26% more shares of JNJ to its portfolio, raising its holding to 3.49 million shares of worth $551.63M. CHARLES SCHWAB INVESTMENT MANAGEMENT INC also increased its JNJ shares holding by 1.46% which brought its holding to 16.18 million shares worth $2.54B.

The insider with the most stakes in JNJ is Taubert Jennifer L , EVP, WW Chair, Pharmaceuticals at the company. Additionally, JNJ stock is highly held by Exec VP, Chief HR Officer Fasolo Peter and See Remarks Hait William among others.

Company executives, directors, and other insiders own 0.06% percent of Johnson & Johnson's stock. Within the last six months, there have been 1 transaction(s) in which JNJ insiders have sold stock, totaling 5.64K shares. Insiders that have sold shares include DECKER ROBERT J, BROADHURST VANESSA, and TAUBERT JENNIFER L.

There have been 1 transaction(s) during the past 6-months in which Johnson & Johnson insiders have bought stock, totalling 1000 shares

Around 19.97K Johnson & Johnson shares are held by insiders, which represents about 0.06% of JNJ stock.

JNJ EVP, WW Chair, Pharmaceuticals, Taubert Jennifer L holds the largest portfolio of the company's shares. JNJ shares owned by Taubert total nearly 141.42 thousand.

GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC is the largest institutional owner in JNJ which holds 4.83 million shares worth $763.67M or 0.2% of the total JNJ shares outstanding followed by CANADA PENSION PLAN INVESTMENT BOARD with ownership of 3.49 million shares representing 0.14% of the JNJ ownership. CHARLES SCHWAB INVESTMENT MANAGEMENT INC is the third largest stakeholder with 16.18 million shares or 0.67% of the ownership worth more than $2.54B.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the JNJ is concerned, it is a stock which is optionable.

Number of JNJ shares short is 16.46M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 2.41B shares of JNJ are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, JNJ has 2.40B shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for JNJ is 1.94.